This is just beginning. There was Pre-FB and now Post-FB. CVSI is making the necessary adjustments accordingly (Salesforce, new hires and audit firm and production expansion). More scientific studies. Management is using D MacKay when talking to the FDMs. I like that very much.
I see what's happening with the stock price after a major broad market correction and the FDA hearing, which has all the CBD investors shaking, as probably the last big opportunity to get in cheap. Any other material PR will send this stock flying.